| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |